Comments on: Eli Lilly Secures Rights to Alchemab’s Early-Stage ALS Drug in $415M Deal https://lifescivoice.com/eli-lilly-secures-rights-to-alchemabs-early-stage-als-drug-in-415m-deal/ Life Sciences Voice | The leading resource for life sciences industry executives. Fri, 09 May 2025 04:21:30 +0000 hourly 1 https://wordpress.org/?v=6.8.1